Rosetta Genomics (ROSG) Continues Recent Surge

May 23, 2012 10:15 AM EDT
Get Alerts ROSG Hot Sheet
Trade ROSG Now!
Join SI Premium – FREE
Rosetta Genomics, Ltd. (Nasdaq: ROSG) is seeing sharp upside today. Shares are up 16 percent currently to $8.62.

Shares have been en fuego since May 16th when the company announced that Novitas, the designated Medicare Administrative Contractor for the Company's miRview mets assay, informed Rosetta that it plans to cover this assay for all Medicare beneficiaries.

A direct equity offering following that huge May 16th pop slowed the stock down for a day, but it has been all uphill since.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Momentum Movers

Add Your Comment